Janux Therapeutics JANX
NASDAQ JANX
$12.26 +0.22 (+1.79%)
As of: Nov 11, 2026 · 3:23 PM EST

Janux Therapeutics (JANX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Janux Therapeutics (JANX) reported Return on Capital Employed [ROCE] of -14.99% for Q2 2026, down 0.79 percentage points from -14.20% a year earlier but up 1.43 percentage points from the prior quarter.

Analysis

Janux Therapeutics (JANX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Janux Therapeutics posted Return on Capital Employed [ROCE] of -15.66%, down 1.61 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a four-year change of +2.11 percentage points (FY2021 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -14.05% in FY2024 (+6.27 pp), -20.32% in FY2023 (-1.44 pp), -18.88% in FY2022 (-1.10 pp) and -17.78% in FY2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -23.48% in Q2 2023 and a high of -5.53% in Q3 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of +0.38 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2024 (a gain of 13.76 percentage points); the low point was Q3 2022 (a drop of 11.58 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -16.42% (Q1 2026), -15.96% (Q4 2025) and -14.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Janux Therapeutics 736.54 Mn -3.10 Bn - -14.82%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -14.82%
Jun 30, 2026 -14.99%
Mar 31, 2026 -16.42%
Dec 31, 2025 -15.96%
Sep 30, 2025 -14.42%
Jun 30, 2025 -14.20%
Mar 31, 2025 -10.94%
Dec 31, 2024 -11.48%
Sep 30, 2024 -12.72%
Jun 30, 2024 -9.72%
Mar 31, 2024 -13.90%
Dec 31, 2023 -19.69%
Sep 30, 2023 -21.48%
Jun 30, 2023 -23.48%
Mar 31, 2023 -21.56%
Dec 31, 2022 -18.99%
Sep 30, 2022 -17.11%
Jun 30, 2022 -15.16%
Mar 31, 2022 -12.22%
Dec 31, 2021 -8.84%
API Access

Janux Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=JANX&period=max&api_key=YOUR_API_KEY